Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer-Reference-Cited by-同舟云学术

Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

Published:2018-03-21 Issue:5 Volume:51 Page:1702431
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Zugazagoitia Jon,Biosca Mercedes,Oliveira Julio,Olmedo María Eugenia,Dómine Manuel,Nadal Ernest,Ruffinelli José Carlos,Muñoz Nerea,Luna Ana María,Hernández Berta,Martínez Maite,Gallego Iria,Martínez de Castro Eva,Font Carme,Calvo Virginia,Martínez-Marín Virginia,Corral Jesús,Noguerón Esther,Mondéjar Rebeca,García Escobar Ignacio,Salvador-Coloma Carmen,Juan Óscar,Sánchez Cánovas Manuel,Valdivia Javier,Ochoa M. Pilar,López Castro Rafael,Obispo Berta,Pangua Cristina,Sereno María,Fernández Franco Lourdes,Mielgo Xabier,Calzas Julia,Blasco Ana,Aparisi Francisco,Chara Luis,Grau Juan Francisco,Soares Marta,Gómez Ana,Zenzola Victor,García-Morillo Marcial,Cacho Diego,Díaz-Serrano Asunción,Aguado Carlos,Ponce-Aix Santiago,González-Larriba Jose Luis,Muñoz Andrés J.,Lora David^ORCID,Paz-Ares Luis,Manzano Aránzazu

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis

2. High Risk of Deep Vein Thrombosis in Patients with Non-small Cell Lung Cancer: A Cohort Study of 493 Patients

3. Venous thromboembolism and nonsmall cell lung cancer

4. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

5. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation;Journal of Oncology Pharmacy Practice;2024-04-05

2. Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer;Thrombosis Research;2023-12

3. In Vitro Assessment of Antiviral, Antimicrobial, Antioxidant and Anticancer Activities of Ulvan Extracted from the Green Seaweed Ulva lactuca;Thalassas: An International Journal of Marine Sciences;2023-08-07

4. Application of Machine Learning to the Prediction of Cancer-Associated Venous Thromboembolism;2023-05-08

5. Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica;Revista Española de Patología;2023-04